Christine Ring, a chief legal officer at Nurix Therapeutics, Inc., sells $103,986 of stock
The chief legal officer sold at an average of $26.28 a share, according to a Form 4 filed with the SEC on Nov 2.
Christine Ring sold $103,986 of Nurix Therapeutics, Inc. (NRIX) stock on Oct 30, according to an SEC filing. The chief legal officer received an average of $26.28 for 3,957 shares.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. After the trade, the filing lists 15,335 shares held.
The filing came 3 days after the trade.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Nurix Therapeutics, Inc. (NRIX) |
|---|---|
| Insider | Christine Ring |
| Role | Chief Legal Officer |
| Transaction | Open-market sale (code S) |
| Shares | 3,957 |
| Average price | $26.28 |
| Value | $103,986 |
| Trade date | Oct 30, 2026 |
| Filed with the SEC | Nov 2, 2026, 7:44 PM ET |
| Shares held after | 15,335 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See every transaction in this Nurix Therapeutics, Inc. filing
Follow NRIX for the next insider trade · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
